Clinical Research Directory
Browse clinical research sites, groups, and studies.
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
Sponsor: PROCEPT BioRobotics
Summary
The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.
Key Details
Gender
MALE
Age Range
Any - 80 Years
Study Type
INTERVENTIONAL
Enrollment
125
Start Date
2022-11-22
Completion Date
2027-03
Last Updated
2026-01-28
Healthy Volunteers
No
Interventions
Robotic Waterjet Treatment
The Aquablation therapy is a minimally invasive, image-guided, heat-free robotic therapy delivered by the AQUABEAM Robotic System. During Aquablation therapy, the AQUABEAM Handpiece is inserted transurethrally into the prostatic urethra. The operating physician then utilizes cystoscopy in conjunction with transrectal ultrasound (TRUS) imaging for real time visualization. The AQUABEAM Robotic System utilizes high-velocity sterile saline waterjet to resect and remove the prostate tissue according to the operating physician's treatment plan.
Locations (6)
San Diego Clinical Trials
La Mesa, California, United States
Endeavour Health (NorthShore University HealthSystem)
Glenview, Illinois, United States
Potomac Urology Center
Alexandria, Virginia, United States
The Chinese University of Hong Kong
Hong Kong, Hong Kong
American University of Beirut
Beirut, Lebanon
Tauranga Urology Research Ltd
Tauranga, New Zealand